Qin Lu

Dr. Qin Lu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2022 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
YLYajie Li
Yajie Li
QLQin Lu
Qin Lu
KWKexuan Wu
Kexuan Wu
XOXilong Ou
Xilong Ou
Objectives. To compare the ability of six preendoscopic scoring systems (ABC, AIMS65, Glasgow Blatchford score (GBS), MAP(ASH), pRS, and T -score) to predict outcomes of upper gastrointestinal bleeding (UGIB) in older adults. Methods. This was a retrospective study of 602 older adults ( age ≥ 65 ) presenting with UGIB at Zhongda Hospital Southeast University from January 2015 to June 2021. Six scoring systems were used to analyze all patients. Results. ABC had the largest area under the curve (AUC) (0.833; 95% confidence interval (CI): 0.801–0.862) and was significantly higher than pRS 0.696 (95% CI: 0.658–0.733, p < 0.01 ) and T -score 0.667 (95% CI: 0.628–0.704, p < 0.01 ) in predicting mortality. MAP(ASH) (0.783; 95% CI: 0.748–0.815) performs the best in predicting intervention and was similar to GBS, T -score, ABC, and AIMS65. The AUCs for MAP(ASH) (0.732; 95% CI: 0.698–0.770), AIMS65 (0.711; 95% CI: 0.672–0.746), and ABC (0.718; 95% CI: 0.680–0.754) were fair for rebleeding, while those of GBS (0.662; 95% CI: 0.617–0.694), T -score (0.641; 95% CI: 0.606–0.684), and pRS (0.609; 95% CI: 0.569–0.648) were performed poorly. MAP(ASH) performs the best in predicting ICU admission (0.784; 95% CI: 0.749–0.816). All the five scores were significantly higher than pRS ( p < 0.05 for ABC, AIMS65 and T -score, p < 0.01 for GBS and MAP). Conclusions. Mortality, intervention, rebleeding, and ICU admission in UGIB for older adults can be predicted well using MAP(ASH). ABC is the most accurate for predicting mortality. Except for rebleeding, GBS has an acceptable performance in predicting ICU admission, mortality, and intervention. AIMS65 and T -score performed moderately, and pRS may not be suitable for the target cohort.

1 January 2025 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
LCLu Chen
Lu Chen
JJJingjing Jiang
Jingjing Jiang
HLHongxia Li
Hongxia Li
XYXin Yin
Xin Yin
XTXiajiao Tang
Xiajiao Tang
RSRuihua Shi
Ruihua Shi
Background: Endoscopic submucosal dissection (ESD) is the first-line treatment for gastric mucosal lesions. The artificial ulcers caused by ESD can lead to bleeding, perforation, and other adverse events. Objectives: This study aimed to evaluate the efficacy of alternate mucosa–submucosa clip in preventing adverse events following ESD for gastric mucosal lesions. Design: Multicenter retrospective observational study. Methods: Data from 924 patients who underwent ESD for gastric mucosal lesions were retrospectively collected and categorized into completely closed and unclosed groups based on postoperative wound management. The incidence of adverse events and postoperative wound healing rate at 1 and 3 months were compared between the groups, and the factors related to delayed bleeding after ESD were analyzed. Results: The rate of delayed hemorrhage was lower in the completely closed group than in the unclosed group (0.8% vs 7.6%; p < 0.001), and subgroup analysis showed that this effect was consistent across all subgroups. The postoperative abdominal pain score was lower in the completely closed group than in the unclosed group (0 vs 2, p < 0.001). One month postoperatively, the wound healing rate was higher in the completely closed group (77.6% vs 55.1%; p < 0.001). Multivariable analysis showed that the presence of ulcers or scars on the lesion surface, and lesions located in the lower one-third of the stomach were risk factors for postoperative bleeding. Conclusion: Application of alternate mucosa–submucosa clip closing the wound of ESD reduced the risk of postoperative bleeding, alleviated postoperative abdominal pain, and promoted artificial wound healing.

8 August 2024 in Cellular Signalling
Verified
Journal Article
Closed access
MSMingyang Song
Mingyang Song
MXMin Xu
Min Xu
QZQi Zhang
Qi Zhang
TFTingyu Fan
Tingyu Fan
JXJiajia Xu
Jiajia Xu
QLQin Lu
Qin Lu

18 February 2026 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
LCLu Chen
Lu Chen
YFYadong Feng
Yadong Feng
YLYang Liu
Yang Liu
ZWZhi Wang
Zhi Wang
QLQin Lu
Qin Lu
RSRuihua Shi
Ruihua Shi
Background: Laparoscopic appendectomy (LA) is the conventional treatment for chronic appendicitis. Endoscopic direct-vision appendicitis therapy (EDAT) has emerged as a minimally invasive, organ-preserving alternative. Objectives: To compare the efficacy and safety of EDAT versus LA in chronic appendicitis. Design: Multicenter retrospective cohort study with propensity score matching (PSM). Methods: This multicenter retrospective cohort study was conducted in China between January 2019 and February 2024. PSM was performed to minimize selection bias. A total of 186 patients with chronic appendicitis were included, including 63 who received EDAT and 123 who underwent LA. The primary outcome was the clinical success rate. The secondary outcomes included the technical success rate, duration of hospitalization, adverse event rate, and recurrence rate. Results: Compared with LA, EDAT showed comparable clinical success (95.2% vs 100%, p = 0.068) and technical success rates (96.8% vs 98.4%, p = 0.877). EDAT reduced the duration of hospitalization (median 2 vs 3 days, p < 0.001) and short- and long-term overall adverse event rates (6.4% vs 45.5% and 7.9% vs 21.1%, respectively; p < 0.001, p = 0.022). At 6, 24, and 48 h postoperatively, the EDAT group had a greater proportion of patients with no pain or mild pain than the LA group did (68.3% vs 40.7% and 90.5% vs 66.7% and 98.4% vs 74.8%, respectively; all p < 0.001). After the 1-year follow-up, the calculated recurrence rate did not differ between the groups (4.8% vs 0%, p = 0.068). Conclusion: Compared with LA, EDAT is a safe, effective, organ-preserving alternative technique for chronic appendicitis, offering a shorter recovery time, reduced adverse event rates, and a low recurrence rate observed during follow-up.

28 May 2025 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YDYuan Ding
Yuan Ding
LCLu Chen
Lu Chen
XYXiaochun Yin
Xiaochun Yin
QLQin Lu
Qin Lu
ZWZhi Wang
Zhi Wang
RSRuihua Shi
Ruihua Shi

7 February 2026 in World Journal of Gastroenterology
Verified
Journal Article
Open access
KYKai-Zhe Yang
Kai-Zhe Yang
LCLu Chen
Lu Chen
LXLi Xu
Li Xu
BXBin-Xiang Xu
Bin-Xiang Xu
MLMing-Yue Li
Ming-Yue Li
QLQin Lu
Qin Lu
BACKGROUND Sarcopenia has been indicated to be related to the postoperative outcome of patients with various digestive tract diseases. However, no studies have investigated the association between sarcopenia and esophageal stenosis after endoscopic submucosal dissection (ESD). AIM To explore the correlation between sarcopenia and post-ESD esophageal stenosis, and subsequently develop a risk prediction model. METHODS Retrospective data from 499 patients who underwent esophageal ESD were collected. After stratification via the L3 skeletal muscle indices (L3-SMIs) into sarcopenia and non-sarcopenia groups, post-ESD stenosis rates were compared. Propensity score matching (PSM) was used for sensitivity analysis. The original cohort was randomly split at a ratio of 7:3 into training (n = 350) and validation (n = 149) groups to construct and validate a risk prediction model for post-ESD stenosis. RESULTS Sarcopenia was significantly associated with post-ESD esophageal stenosis (48.23% vs 22.35%, P < 0.001). Furthermore, multivariate analysis confirmed its independence as a predictor of this postoperative complication [odds ratio (OR): 3.86; 95% confidence interval: 1.76-8.45; P < 0.001]. This conclusion was consistent across the subgroup analyses and PSM analyses. The risk prediction model incorporating sarcopenia had area under the curve values of 0.848 (training set) and 0.794 (validation set). Calibration curves and Hosmer-Lemeshow tests indicated good calibration of the model. Moreover, decision curve analysis confirmed a positive net clinical benefit for the model. CONCLUSION Sarcopenia is an independent risk predictor of post-ESD esophageal stenosis. Our model integrating muscle mass assessment aids in early high-risk identification and intervention.